提供永久免费的API接口，查看更多API接口，如果您有其他免费API资源，请联系我们，造福人类。

定制开发，免费评估，免费咨询，价格便宜，售后保障，前往开发服务中心或联系开发客服中心

Scan the QR code with wechat < / P > < p > to share with friends and circle of friends < / P > < p > at noon on April 14, < a target = "_ blank" href=" https://news.163.com/news/search?keyword=%E5%BA%B7%E5%B8%8C%E8%AF%BA "> Connaught < / a > bio (688185. Sh, 6185. HK) announced that the company has noticed some media reports about < a target ="_ blank" href=" https://news.163.com/news/search?keyword=%E6%8E%A5%E7%A7%8D "> vaccination < / a > AstraZeneca new crown < a target ="_ blank" href=" https://news.163.com/news/search?keyword=%E7%96%AB%E8%8B%97 "> after vaccination < / a > and Johnson & Johnson new crown vaccine, individuals have rare and severe < a target ="_ blank" href=" https://news.163.com/news/search?keyword=%E8%A1%80%E6%A0%93 "> thrombosis < / a > cases. Chimpanzees used by the company and AstraZeneca new crown vaccine < a target = "_ blank" href=" https://news.163.com/news/search?keyword=%E8%85%BA%E7%97%85%E6%AF%92 "> adenovirus < / a > vector is different from the type 26 adenovirus vector used in Johnson & Johnson new crown vaccine. < p > < p > Connaught bio stressed that as of the announcement date, about one million people vaccinated with recombinant new crown vaccine Ad5 ncov had not received reports of serious adverse events related to thrombosis. < / P > < p > kangxinuo bio's new coronal vaccine has been conditionally listed in China. According to the report of global times on April 4, 150000 doses of kangxinuo bio's new coronal vaccine with adenovirus vector have successively arrived in Yunnan, which will help the people in Dehong Prefecture, including Ruili, to complete the vaccination as soon as possible. < / P > < p > < p > kangxinuo biological new crown vaccine belongs to the technology route of adenovirus vector, and belongs to the same technology route as AstraZeneca / Oxford new crown vaccine and Johnson & Johnson new crown vaccine, which were involved in thrombosis dispute before. < / P > < p > on April 13, local time, the US Food and Drug Administration (FDA) and the US Centers for Disease Control and Prevention (CDC) announced that they proposed to suspend the vaccination of J & J new crown vaccine out of caution. On the same day, Johnson & Johnson announced that it would delay the delivery of its new crown vaccine in the European Union and suspend vaccination in all clinical trials of the new crown vaccine. < / P > < p > earlier on April 7, the European drug administration and the World Health Organization also issued a statement saying that the AstraZeneca vaccine may be associated with rare thrombosis. < p > < p > affected by the adverse reaction events of new crown vaccine with the same technology route abroad, kangxinuo's share price fell sharply. As of the afternoon of April 14, a shares fell 9.81% to 342.8 yuan, while Hong Kong shares fell 13.43% to 270.8 Hong Kong dollars.

2023-03-22 10:04:32